الفهرس 
Hepatocellular carcinomaOnly 14 pages are availabe for public view
 |  | from | 16 |  |  |
| | | from | 16 | | |
Abstract
HCC is a major health problem in Egypt. Liver
transplantation is a lifesaving and effective treatment of end-stage liver
failure. However transplant recipients can suffer from serious side effects
of long-term immunosuppression and they can lose their allografts
because of rejection. Our aim is to evaluate the value of serum miR-122 ,
miR-194 and miR-148a as biomarkers for diagnosis of rejection after
liver transplantation.
Subject and Methods: Blood samples were taken from 30 patients who
prepared to liver transplantation process. Also 50 blood samples from
controls were taken.
The following were done: history taking, general examination, complete
blood picture, liver function tests, hepatitis markers by ELIZA. Serum
was separated for detection of: miR-122, miR-194 and miR-148a by real